Submitted by Anonymous (not verified) on 13 August 2025 - 14:27
Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised